Aem 4160 strategic pricing prof jura liaukonyte lecture 10 pricing gardasil
This presentation is the property of its rightful owner.
Sponsored Links
1 / 35

AEM 4160: Strategic Pricing Prof.: Jura Liaukonyte Lecture 10 Pricing Gardasil PowerPoint PPT Presentation


  • 122 Views
  • Uploaded on
  • Presentation posted in: General

AEM 4160: Strategic Pricing Prof.: Jura Liaukonyte Lecture 10 Pricing Gardasil. QALY. The quality-adjusted life year (QALY) is a measure of disease burden, including both the quality and the quantity of life lived. It is used in assessing the value for money of a medical treatment.

Download Presentation

AEM 4160: Strategic Pricing Prof.: Jura Liaukonyte Lecture 10 Pricing Gardasil

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -

Presentation Transcript


Aem 4160 strategic pricing prof jura liaukonyte lecture 10 pricing gardasil

AEM 4160: Strategic PricingProf.: Jura LiaukonyteLecture 10 Pricing Gardasil


Aem 4160 strategic pricing prof jura liaukonyte lecture 10 pricing gardasil

QALY

  • The quality-adjusted life year (QALY) is a measure of disease burden, including both the quality and the quantity of life lived.

  • It is used in assessing the value for money of a medical treatment.

  • The QALY is based on the number of years of life that would be added by the treatment.

  • Each year in perfect health is assigned the value of 1.0 down to a value of 0.0 for death.


Aem 4160 strategic pricing prof jura liaukonyte lecture 10 pricing gardasil

QALY

  • Used in cost-utility analysis to calculate the ratio of cost to QALYs saved for a particular health care treatment.

  • Helpful in allocating healthcare resources,

    • Treatment with a lower cost to QALY saved ratio being preferred over an intervention with a higher ratio.

    • Controversial: some people will not receive treatment because it is too costly

    • Cost per QALY under $50,000 is acceptable


Value of statistical life

Value of Statistical Life

  • An economic value assigned to life in general,

  • Marginal cost of death prevention in a certain class of circumstances.

  • As such, it is a statistical term, the cost of reducing the (average) number of deaths by one.


Value of a statistical life and compensating differences

Value of a Statistical Life and Compensating Differences

  • Qa , Qb =probability of fatal injury on job a, b respectively in a given year.

  • Wa, Wb = earnings on job a, b in a given year.

  • Assume Qa<Qb so that Wa<Wb.

  • Compensating difference=Wb-Wa

  • Value of a “statistical” life = (Wb-Wa)/(Qb-Qa)

  • Example: If a person is faced with .001 higher risk of death per year and is paid $5000 per year extra for that risk, the value of a statistical life is 5000/.001 - $5,000,000.


Aem 4160 strategic pricing prof jura liaukonyte lecture 10 pricing gardasil

Viscusi. “The Value of a Statistical Life: A Critical Review of Market Estimates Throughout the World.” Journal of Risk and Uncertainty, v. 27 issue 1, 2003, p. 5.


Value of life and compensating differences

Value of Life and Compensating Differences

  • Biases in estimates of statistical value of life

    • Valuation is correct only for “marginal” worker. Estimate is too high for infra-marginal worker, and too low for workers that didn’t accept job with risk.

    • ex post versus ex ante rewards for risk (compensating difference vs. law suits, insurance, etc.)

    • Failure to control for other risks correlated with fatality risk

    • Fatality risk measured with error


Question

Question

  • Is Gardasil a Good Product?


Pricing in the biomedical industry

Pricing in the Biomedical Industry

  • What factors should Merck consider when setting the price?


Factors

Factors:

  • Important or not important?

    • Product cost

    • R&D Investment?

    • Other Vaccines?

    • Public Relations?

    • Value to the Customer/Benefit?

    • Economic Modeling?

    • Competition?


Calculating cost per qaly

Calculating cost per QALY

  • Cost Per QALY = Cost of a quality life year

  • STEP 1: Consider the costs per person:

    • Cost per dose: ___________________

    • Cost per administration:_____________

    • Number of doses: _____________________

    • Total cost per patient: __________________


Step 2

Step 2

  • Additional QALYs per person

    At age 50, further life expectancy without cervical cancer: ____________

    QALY per year: __________________________________________

    Total QALYs: ____________________________________________

    At age 50, further life expectancy with cervical cancer: ______________

    QALY per year: ___________________________________________

    Total QALYs: _____________________________________


Step 21

STEP 2

  • Reduction in QALYs with cervical cancer:_________________

  • Gardasil prevents:______________________________

  • Gardasil incremental QALYs: ________________

  • Chance of Getting cervical cancer without Gardasil: _______________

  • Incremental QALYs per person: ________________________________

  • Cost per QALY:

    • Vaccination: _____________________________________

    • QALY: ____________________________________

    • Cost per QALY:___________________________


Step 2a

Step 2a

  • This was a rough calculation because it left out an important piece of a puzzle:

    • COST SAVINGS

      • Fewer Pap tests

      • Fewer LLETZ procedures

      • Fewer cervical cancers to treat


Step 2a1

Step 2a

  • Calculate COST savings

    • Chance that a woman will have CIN 1: ______________

    • Chance that a woman will have CIN 2/3:______________

    • Chance that a woman will have cervical cancer: ___________

    • Cost to treat CIN 1: ________$55______________

    • Cost to treat CIN2/3: _____________________

    • Cost to treat cervical cancer: ________________


Saved costs per person

Saved Costs per person

  • CIN 1: __________________________________

  • CIN 2/3: ________________________________

  • Cervical cancer: ___________________________

  • Gardasil will prevent (estimates):

    • CIN 1: 50%

    • CIN 2: 70%

    • Cervical Cancer: 70%


Calculate total savings

Calculate total savings:

  • CIN 1: ____________________

  • CIN 2/3: ____________________

  • Cervical cancer: _________________

    • TOTAL SAVINGS: ______________________


Savings now or later

Savings now or later?

  • Vaccine given (average or target): __________

  • Cancer prevents: _______________

  • Difference: ___________________

  • Discount the cost savings at say, 8% = $16.50

    • In excel the command would be: =PV(0.08, 43, ,-450.2)


Savings later

Savings later

  • So the total is”

    • Cost per person: _______________

    • Savings per person: ___________

    • QALY per person: 0.038

    • COST per QALY:__________________

    • Do the risks of a PR backlash and the need to grow quickly outweigh the benefits of a higher price

    • Potential entrant is coming

    • Patent is not forever


360 too low or too high

$360 Too low or too high?

  • Suppose prices are set so that cost of QALY is $30,000

  • What is the maximum price that could be set?

  • x = cost per person

  • (x-16.50)/0.038 = 30,000

  • x =$1156.5

  • Or $1156.5/3 = $385 per dose


Aem 4160 strategic pricing prof jura liaukonyte lecture 10 pricing gardasil

  • ANSWERS TO BLANK SLIDES


Calculating cost per qaly1

Calculating cost per QALY

  • Cost Per QALY = Cost of a quality life year

  • STEP 1: Consider the costs per person:

    • Cost per dose: ____________$120_______

    • Cost per administration:______$20________

    • Number of doses: _________3____________

    • Total cost per patient: ________$420_______


Step 22

Step 2

  • Additional QALYs per person

    At age 50, further life expectancy without cervical cancer: ____31.6 years___

    QALY per year: ______________________________0.8______________

    Total QALYs: _________________0.8*31.6=25.2____________________

    At age 50, further life expectancy with cervical cancer: ______20 years_____

    QALY per year: ______________________________0.8______________

    Total QALYs: _________________0.8*20=16____________________


Step 23

STEP 2

  • Reduction in QALYs with cervical cancer:___25.2-16=9.2___

  • Gardasil prevents:__________________70%____________

  • Gardasil incremental QALYs: _______.7*9.2=6.4_________

  • Chance of Getting cervical cancer without Gardasil: ___0.6%_

  • Incremental QALYs per person: ___________0.006*6.4=0.038_______

  • Cost per QALY:

    • Vaccination: ___________________$420__________

    • QALY: ________________________0.038____________

    • Cost per QALY:_________________420/0.038=$11,053__________


Step 2a2

Step 2a

  • This was a rough calculation because it left out an important piece of a puzzle:

    • COST SAVINGS

      • Fewer Pap tests

      • Fewer LLETZ procedures

      • Fewer cervical cancers to treat


Step 2a3

Step 2a

  • Calculate COST savings

    • Chance that a woman will have CIN 1: _______10%__

    • Chance that a woman will have CIN 2/3:___2.8%___

    • Chance that a woman will have cervical cancer: __0.6%_____

    • Cost to treat CIN 1: ________$55______________

    • Cost to treat CIN2/3: _________$1400____________

    • Cost to treat cervical cancer: _______$100,000_________


Saved costs per person1

Saved Costs per person

  • CIN 1: ________10%*$55=$5.50____________

  • CIN 2/3: ______2.8% * $1400=$39.20_______

  • Cervical cancer: __0.6%*$100,000=$600_____

  • Gardasil will prevent (estimates):

    • CIN 1: 50%

    • CIN 2: 70%

    • Cervical Cancer: 70%


Calculate total savings1

Calculate total savings:

  • CIN 1: ________5.50*50%=$2.75____________

  • CIN 2/3: ______39.20*70%=$27.44__________

  • Cervical cancer: __600*70%=$420___________

    • TOTAL SAVINGS: _____$450.20______


Savings now or later1

Savings now or later?

  • Vaccine given (average or target): ___Age 11____

  • Cancer prevents: _____Age 54_____

  • Difference: _____________43 years______

  • Discount the cost savings at say, 8% = $16.50

    • In excel the command would be: =PV(0.08, 43, ,-450.2)


Savings later1

Savings later

  • So the total is”

    • Cost per person: ________$420_______

    • Savings per person: ______$16.50_____

    • QALY per person: 0.038

    • COST per QALY: $10,618.00

    • Do the risks of a PR backlash and the need to grow quickly outweigh the benefits of a higher price

    • Potential entrant is coming

    • Patent is not forever


360 too low or too high1

$360 Too low or too high?

  • Suppose prices are set so that cost of QALY is $30,000

  • What is the maximum price that could be set?

  • x = cost per person

  • (x-16.50)/0.038 = 30,000

  • x =$1156.5

  • Or $1156.5/3 = $385 per dose


Advertising and pricing

Advertising And PRICING


Stylized facts about advertising

Stylized Facts About Advertising

  • Volume of advertising expenditures is large. For the US, advertising consumes over 2% of GDP

  • Underneath this national total is a wide variety in firm advertising behavior

  • Car makers (e.g., GM) and household product firms (e.g., Proctor & Gamble) spend the most on advertising

  • Basic patterns that emerge are:

    • Correlation between advertising & market power

    • Consistency of advertising behavior within industries—big advertisers remain big over time and across countries


Advertising and monopoly power

Advertising and Monopoly Power

  • Assume a firm faces a downward-sloping demandinverse curve but one that shifts depending on the amount of advertising A that the firm does

    P=P(Q, A)

  • Recall, the Lerner Index, LI

L = (p - MC)/p = 1/|EP|

Where |EP| is the price elasticity of demand


Advertising and monopoly power1

Advertising and Monopoly Power

  • The elasticity of output demand with respect to advertising A is defined as

  • We can derive the following relationship:

= Advertising/sales ratio

Dorfman-Steiner Condition:For a profit-maximizing monopolist, the advertising-to-sales ratio is equal to the ratio of the elasticity of demand with respect to advertising relative to the elasticity of demand with respect to price.


  • Login